Surgical Mesh Market

Key data points: Market size in 2027 = $2.6 billion and 2035 = $4.5 billion, growth forecast = 8.0% annually for the next 8 years. Scroll below to get more insights. This market report covers trends, opportunities and forecasts in surgical mesh market to 2035 by type (synthetic materials, biological materials, and others), application (hernia surgery, pelvic surgery, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World) Surgical Mesh Market The future of the global surgical mesh market looks promising with opportunities in the hernia surgery and pelvic surgery markets. The global surgical mesh market is expected to reach an estimated $4.5 billion by 2035 from $2.6 billion in 2027 with a CAGR of 8.0% from 2027 to 2035. The major drivers for this market are the growing prevalence of obesity-related disorder, the rising incidence of chronic abdominal condition, and the increase in the geriatric population. • Lucintel forecasts that, within the type category, synthetic materials is expected to witness higher growth over the forecast period due to more affordable synthetics and greater demand for hernia repair surgeries. • Within the application category, hernia surgery is expected to witness higher growth over the forecast period due to increased need for surgical services and facility expansion. • In terms of regions, APAC is expected to witness the highest growth over the forecast period due to fewer restrictions in less developed countries. Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below. Emerging Trends in Surgical Mesh Market Surgical mesh market is shifting toward using safer products, even if it means using different mesh products for different surgical procedures. Approximately 2025 to 2027, surgical mesh manufacturers will be assessed more strictly on the clinical evidence supporting their products. Meanwhile, hospitals will be assessing mesh products based on the average complication rate and cost-effectiveness. Although multiple alternatives are in the research and development phase, Lucintel predicts that many surgical mesh products in the future will be made of different types of polymers and will be designed to be used along with robotic systems for hernia and pelvic floor repair. • Resorbable Mesh: Manufacturers will likely launch mesh products reinforced with temporary structures. Long-term (2025) and post-market studies will evaluate the safety and eff tire of resorbable mesh products. • Patient-specific Design: The use of computers and other advanced imaging and fabrication systems will enable more precise design and construction of surgical implants. In 2025, a small number of studies evaluated the use of advanced imaging and design to create surgical implants for abdominal wall reconstruction. Similar techniques will also be used to construct surgical implants for other wall and floor systems of the body. • Evidence-based Safety: To gain or maintain marketing clearance for a surgical device, manufacturers will need to provide clinical evidence (i.e. outcomes) in addition to post-market surveillance data and registries. • Increased Demand for Minimally Invasive Surgical Meshes: Advancements in medical technology have increased the global prevalence of robotic surgical procedures and enhanced the design of surgical instruments and implants. Additionally, there is a focus on developing meshes that require less fixation and decrease the burden on the body. • Improved Supply Chain Flexibility: There has been a shift toward increased flexibility within the supply chain. Some examples of this include leveraging more than one source of supply for raw materials, utilizing more than one location for the final stage of a product’s manufacture, and improving supply chain planning and management. This has encouraged previously limited capacity medical device manufacturers to increase their output. In the near term, the surgical mesh market is expected to be flat. However, advancements in surgical and procedural techniques in conjunction with new mesh technologies may allow for the market to expand. Recent Developments in the Surgical Mesh Market Surgical mesh market is expected to grow during the period 2025-2026. However, there are stringent rules for evidence and continuous scrutiny for product liability. Lucintel is aware of the trend toward the use of advanced and absorbable materials for hernia repair, and the use of robotic systems for surgical mesh repair. Innovation is to strengthen the healthcare system through expansion of existing capacity and to cement long-term partnerships with healthcare systems. • Absorbable Mesh: There is a growing trend toward the use of resorbable mesh; TELA Bio reported revenue of about $54.1 million in 2025 (reported in March 2026). Use of resorbable mesh for hernia repair facilitates premium reimbursement if data supports it to be cost effective. • Biologic Mesh: Suppliers are developing and offering reinforced biologic mesh for repair of complex abdominal wall defects; Integra reported revenues of about $1.6 billion in 2025 (reported in February 2026). • Strong Surveillance: The FDA issued 21 warning letters in the month of January 2026. This indicates that post-market surveillance of medical devices will be stringent. • Consolidation of Hospital Contracts: There is a trend toward standardization of contracts by buying groups for surgical mesh, repair kits, and educational aids; as of 2025 (reported in February 2026) Premier, Inc. served about 4400 hospitals. • Robotic Procedure Integration (RPI): The integration of robotic systems has allowed businesses to adjust their packaging and delivery systems to focus on minimally invasive procedures. As of January 2026, it is estimated that Intuitive Surgical will have 2,300 da Vinci systems placed. Growing acceptance and use of robotic systems will probably create a growing market for small, derived-positioned implants, in the next 3-5 years. In the next 5 years, the surgical mesh market will see more growth as a result of advances in clinical safety and efficacy, rather than growth in volume. In this time period, the use of biologic mesh products will likely increase. To sustain market position, companies will seek to ensure that their products are supported by sufficient clinical data to demonstrate that use of their product results in improved outcomes as compared to currently on the market products. Products that do not meet this requirement will face decreased market acceptance. Strategic Growth Opportunities in the Surgical Mesh Market Surgical mesh markets will continue to expand beyond hernia repair between 2024 and 2026. Popular demand will be for products with evidence of effect and design to address specific issues. Based on these trends, Lucintel expects positive business potential for companies that can provide products supported by post-market evidence and services. • Regenerative Biomaterials: From a patient safety and risk-management perspective, the use of biologic or bioresorbable polymers in mesh will address chronic, and perhaps only disagreeable, posteriori foreign body reactions. From a business perspective, the adjacent service/product markets represented by the surgical devices and implants business unit of Medtronic (approximately $33.5 billion in fiscal year 2024) provide an opportunity. • Robotic Surgery and MIS: The use of lightweight mesh in MIS and robotic surgery will ease the surgeon’s burden in placing and positioning the mesh. With nearly 2.4 million procedures performed using the da Vinci Surgical System in 2024, the need for specialized mesh to be used in conjunction with MIS and robotic surgery will no doubt increase. • Women's Health: FDA regulations for transvaginal mesh devices are expected to stimulate development of pelvic mesh and surgical devices for other pelvic floor and abdominal wall reconstructive surgeries. Stronger evidence will help build the case for use of these devices in other surgical indications. • Emerging Markets: Lower priced products will help facilitate access to mesh in Middle East, Latin America and South East Asia. Reliable supplies of affordable mesh will fill a critical need. The World Bank’s June 2025 report indicated that 75% of the world’s population lives in middle income countries. • Technology: Combining computer-aided planning with 3-D printing will allow creation of mesh implants tailored to a patient’s specific anatomy. It is anticipated that this technology, along with improved surgical instrumentation and integration of advanced imaging, will transform the field of surgery in the next 5 to 10 years. There is a clear and immediate need to improve care and outcomes of women who require surgical intervention. Focus should be on those areas where it is mutually beneficial for manufacturers, health care systems, and payers to invest. Prioritizing areas for regulation and quality systems will help maintain premium status for companies in a competitive market. Surgical Mesh Market Drivers and Challenges Advances in medical technology combined with an increase in the number of surgeries has created a greater demand for surgical meshes. However, the economics of the industry and inconsistent regulations have created barriers for widespread market acceptance. The trend toward less-invasive surgeries and the development of new biomaterials create a long-term positive outlook for the surgical mesh market. On the other hand, concerns about product safety and the potential for infection continue to pose challenges. The factors responsible for driving this market include : • Increasing Number of Surgical Procedures: The consequences of health and economic burdens of obesity including hernias have resulted in an increased demand for repair surgeries. As of 2025, over 1 billion people were estimated to be suffering from obesity and other related conditions. Concurrently, increased focus on public health has improved access to surgeries and made diagnosis of hernias easier in less developed countries. It is expected that higher surgical volumes in the coming years will result increased use of surgical mesh. • Technology Improvements: New mesh technologies such as those that are lightweight and absorbable have improved the flexibility of meshes. The use of biologic materials in mesh is also improving post-operative pain and hastening the integration of the mesh to tissue. Polymer research has progressed to create meshes that, during the healing process, maintain the strength of the mesh and once healed, gradually degrade. As this research progresses and the barriers to the technology are reduced, manufacturers will be able to create meshes that alleviate pain and other problems associated with the use of permanent meshes. • Minimally Invasive Procedures: Advances in mesh technology, particularly in robotically and laparoscopically assisted surgery, is creating a market for special designs that can be inserted through smaller incisions. Robotic systems exceeding 10,000 installations created a need for accompanying fixation and shaped systems. Continued emphasis on mesh technology will bring new, differentiated products and facilitate the transition to less invasive surgeries that benefit patients by reducing their length of stay and time to heal. • Regulatory and Clinical Support: As the demands for better documentation increases, manufacturers are better positioning themselves by differentiating themselves from competitors. Concurrently, the European union implemented the Medical Device Regulation to increase the oversight of and demands on the manufacturers. While the increased requirements and costs negatively effect the manufacturers, better data and safety investigations will benefit increase the use of differentiated products. • Manufacturing Innovations and Product Advancements: Enhancements in polymer and mesh manufacturing boost consistency and reduce waste. There has also been progress in automating the testing of mesh for various defects. Digitally controlled production systems were even more prevalent in 2025. These systems allowed for real time monitoring of a number of quality metrics. In the next 3 to 5 years, real time monitoring and other recent technological innovations may allow manufacturers to create and supply customized meshes at mass volumes at lower costs. The challenges facing this market include: • Patient Concerns and Adverse Events: The worst case scenarios associated with surgical mesh, namely infection and the need for additional surgeries, are of greatest concern to patients. These events occur for a number of reasons including adhesions and erosions. Surgical mesh, like other medical devices, is intended to help patients and improve quality of life. When mesh fails to do this, or if it creates new conditions, it may limit a patient’s faith in the healthcare system. In 2025, surgical site infections occurred in about 2% of all inpatient surgical procedures, providing further impetus for improving mesh safety. • Lawsuits and Regulation: Mesh manufacturers face elevated risk and cost while trying to meet new standards. Many manufacturers extend the warranties on their devices and perform post-market surveillance for thousands of products. In 2025, the trend toward greater product liability and regulation continued. It is possible that smaller manufacturers will be acquired or exit the marketplace. • Cost and Reimbursement Constraints: Recent trends have shown that costs associated with various meshes and robotic procedures have gone up due to lack of adequate reimbursement. Healthcare providers have had to bear these increased costs. Healthcare inflation has been over 2% for a number of years, and is expected to continue. During the next three to five years, the cost of Healthcare provider first priority is cost reduction for readmission and reduction in complication rates. Only then would they consider using a more expensive surgical mesh product. Surgical Mesh Products Manufacturers should invest in product research to create new products that are safe, lightweight, and innovative, as well as meet the needs and requirements of the healthcare industry. Manufacturers should focus on creating a product with the best clinical evidence. From an economic perspective, various markets offer good potential for surgical mesh products. This potential is however, constrained by the existing regulations and the levels of safety and clinical evidence. The levels of safety and clinical evidence required are higher for certain regions (Europe and the U.S.) as compared to the Rest of the World. In the long term, emerging markets also present potential for surgical mesh products List of Surgical Mesh Market Companies Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies surgical mesh market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the surgical mesh market companies profiled in this report include- • BD • B. Braun • Cook Medical • Johnson & Johnson • Gore Medical Surgical Mesh Market by Segment The study includes a forecast for the global surgical mesh market by type, application, and region. Surgical Mesh Market by Type [Value ($B) from 2019 to 2035]: • Synthetic Materials • Biological Materials • Others Surgical Mesh Market by Application [Value ($B) from 2019 to 2035]: • Hernia Surgery • Pelvic Surgery • Others Surgical Mesh Market by Region [Value ($B) from 2019 to 2035]: • North America • Europe • Asia Pacific • The Rest of the World Country Wise Outlook for the Surgical Mesh Market Changes in scope of regulation, investments and mergers in the surgical mesh market have resulted in shrinking number of competitors. Leading firms have focused on developing mesh products incorporating absorbable materials and disseminating clinical evidence to support use in specific indications. From 2025 to 2027, mesh products designed for robotically assisted surgery will be increasingly offered. According to Lucintel, ongoing changes in the market have shifted competitive positioning of firms. Regulatory and business strategies of competing firms will determine market success. • United States: The Food and Drug Administration (FDA) has requested that pelvic and hernia mesh manufacturers provide additional post-market data and has restricted their use to limited indications. In 2025, the FDA announced 14 medical device recalls and safety communications related to mesh products. The FDA’s focus has prompted other mesh manufacturers to develop and provide post-market data to support their products. Suppliers with meshes supported by clinical data will be successful in the market. • China: Between 2013 and 2023, the China Food and Drug Administration (CFDA) approved over 250 novel medical devices. The localization strategy has encouraged several China-based firms to establish local manufacturing facilities for high-value mesh products. Procurement cycles for mesh products will be shortened and competitive pressure on imported products will increase in the next 3-5 years. • Germany: Manufacturers are creating systems to include clinical evaluation and traceability as part of their EU MDR conformity processes. In May 2025, the European Commission announced that it had received more than 40,000 MDR conformity assessments. Large companies will have a competitive advantage because they will have the resources to hire staff, perform tests, and monitor the MDR products once they are on the market. • India: The Indian government is promoting the local production of implantable devices. In February 2025, the Indian Department of Pharmaceuticals announced the third list of beneficiaries of the Pharma PLIS (Production-Linked Incentive Scheme) worth ₹3,420 crore (~USD 453 million). The scheme will increase the local production of mesh devices. • Japan: Japan’s health ministry is focused on approving medical devices that minimize trauma during surgeries. The ministry also set a 1.5% reimbursement rate increase (effective from April 2025) for implantable devices. Mesh devices that are approved by the ministry will be adopted across hospitals in Japan. Features of the Global Surgical Mesh Market Market Size Estimates: surgical mesh market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions. Segmentation Analysis: surgical mesh market size by type, application, and region in terms of value ($B). Regional Analysis: surgical mesh market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the surgical mesh market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the surgical mesh market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model. If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more. This report answers following 11 key questions: Q.1. What are some of the most promising, high-growth opportunities for the surgical mesh market by type (synthetic materials, biological materials, and others), application (hernia surgery, pelvic surgery, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)? Q.2. Which segments will grow at a faster pace and why? Q.3. Which region will grow at a faster pace and why? Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market? Q.5. What are the business risks and competitive threats in this market? Q.6. What are the emerging trends in this market and the reasons behind them? Q.7. What are some of the changing demands of customers in the market? Q.8. What are the new developments in the market? Which companies are leading these developments? Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth? Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution? Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?